Role of Dentist: COVID19 and Mucormycosis

J Pharm Bioallied Sci. 2022 Jul;14(Suppl 1):S2-S6. doi: 10.4103/jpbs.jpbs_734_21. Epub 2022 Jul 13.

Abstract

Dental practice has evolved over time and has adapted to the challenges that it has faced. The risk of infection spread via droplet and airborne routes poses a significant risk to the dentist who works close to patients. The risk of cross-infection between dental health-care personnel and patients can be very high due to the peculiar arrangements of dental settings. Dental clinics should have air purification systems with high volume excavators and negative pressure rooms for COVID-19 screening. Mucormycosis is a fungal disease that mostly occurs in immunocompromised individuals and those with uncontrolled diabetes. Dental extraction can trigger the occurrence. Increased occurrence of mucormycosis is seen in COVID-affected patients. This article gives a review on the dentistry-related transmission of COVID 19, the relation of COVID and mucormycosis.

Keywords: COVID 19; SAR CoV-2; rhino cerebral mucormycosis.

Publication types

  • Review